JPMORGAN CHASE & CO - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is and the CUSIP is G6674U958. A total of 5 filers reported holding NOVOCURE LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of NOVOCURE LTD
ValueSharesWeighting
Q4 2022$5,663
-95.6%
77,200
+4441.2%
0.00%
Q3 2022$129,000
+43.3%
1,700
+30.8%
0.00%
Q2 2022$90,000
-98.6%
1,300
-98.3%
0.00%
-100.0%
Q1 2022$6,338,000
+5363.8%
76,500
+7550.0%
0.00%
Q3 2021$116,000
-98.9%
1,000
-98.3%
0.00%
-100.0%
Q4 2020$10,382,000
+670.7%
60,000
+200.0%
0.00%
Q1 2020$1,347,00020,0000.00%
Other shareholders
NOVOCURE LTD shareholders Q4 2021
NameSharesValueWeighting ↓
PURA VIDA INVESTMENTS, LLC 93,800$7,043,0000.26%
GROUP ONE TRADING, L.P. 115,900$8,702,0000.01%
HBK INVESTMENTS L P 18,000$1,351,0000.01%
SIMPLEX TRADING, LLC 43,800$3,288,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NOVOCURE LTD shareholders